Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Aliment Pharmacol Ther. 2010 Oct 5;32(11-12):1373–1382. doi: 10.1111/j.1365-2036.2010.04476.x

Table 3.

EoE Diagnosis

All Respondents (n= 72) Academic GI (n= 34) Community GI (n=38) p-value *
Do you put biopsies from different locations in different pathology jars: (% yes) 65% 79% 53% 0.02
From where in the esophagus do you take biopsies:
Proximal + Middle + Distal (%) 44% 47% 42% NS
Proximal + Distal (%) 33% 44% 24% NS
Middle + Distal (%) 14% 6% 21% NS
Proximal + Middle (%) 4% 3% 5% NS
Middle only (%) 4% 0% 8% NS
Do you require that a patient is on a PPI prior to making the diagnosis of EoE: (% yes) 31% 44% 18% 0.02
 If yes, do you use once daily or twice daily dosing?
  Once daily 45% 53% 29% NS
  Twice daily 55% 47% 71% NS
 If yes, what is the duration of treatment?
  Range (weeks) 4 –12 4 –8 4 –12
  Mean ± s.d. 6 ± 2 6 ± 2 6 ± 3 NS
Which of the following do you require to make the diagnosis of EoE:
Positive biopsy only 15% 9% 21% NS
Consistent symptoms only 0% 0% 0% NS
Consistent symptoms + Positive biopsy 19% 24% 16% NS
Positive endoscopy findings + Positive biopsy 10% 3% 16% NS
Consistent symptoms + Positive Biopsy + One of the following: No clinical response to a PPI, No histologic response to a PPI, and/or Negative pH testing** 13% 24% 3% 0.007
Consistent symptoms + Positive endoscopy findings + Positive biopsy + One of the following: No clinical response to a PPI, No histologic response to a PPI, and/or Negative pH testing 15% 15% 16% NS
Consistent symptoms + Positive endoscopy findings + Positive biopsy 26% 27% 26% NS

EoE, eosinophilic esophagitis; GI, gastroenterologist; NS, not significant

*

Comparison between academic and community GI performed with 2 sample t-test, Pearson’s chi-square test or Fisher’s Exact Test

**

EoE Consensus Guidelines